140 related articles for article (PubMed ID: 10921334)
1. [Hereditary prostate cancer].
Nakata S; Ohtake N; Takei T; Yamanaka H
Nihon Rinsho; 2000 Jul; 58(7):1515-8. PubMed ID: 10921334
[TBL] [Abstract][Full Text] [Related]
2. [Genetic, epidemiologic and clinical study of familial prostate cancer].
Valéri A
Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
[TBL] [Abstract][Full Text] [Related]
3. Hereditary aspects of prostate cancer.
McLellan DL; Norman RW
CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
[TBL] [Abstract][Full Text] [Related]
4. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
Alberti C
Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
[TBL] [Abstract][Full Text] [Related]
7. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.
Elkins DA; Yokomizo A; Thibodeau SN; J Schaid D; Cunningham JM; Marks A; Christensen E; McDonnell SK; Slager S; J Peterson B; J Jacobsen S; R Cerhan J; L Blute M; J Tindall D; Liu W
Prostate; 2003 Jun; 56(1):30-6. PubMed ID: 12746844
[TBL] [Abstract][Full Text] [Related]
10. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
[TBL] [Abstract][Full Text] [Related]
11. Familial risk factors for prostate cancer.
Carter BS; Steinberg GD; Beaty TH; Childs B; Walsh PC
Cancer Surv; 1991; 11():5-13. PubMed ID: 1841757
[TBL] [Abstract][Full Text] [Related]
12. [Genetic susceptibility to prostate cancer].
Cussenot O; Cancel-Tassin G
Med Sci (Paris); 2004 May; 20(5):562-8. PubMed ID: 15190476
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of genes related to androgen and estrogen metabolism in hereditary versus sporadic prostate cancer.
Fromont G; Yacoub M; Valeri A; Mangin P; Vallancien G; Cancel-Tassin G; Cussenot O
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1505-9. PubMed ID: 18559568
[TBL] [Abstract][Full Text] [Related]
14. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological features of hereditary prostate cancer.
Keetch DW; Humphrey PA; Smith DS; Stahl D; Catalona WJ
J Urol; 1996 Jun; 155(6):1841-3. PubMed ID: 8618269
[TBL] [Abstract][Full Text] [Related]
16. Aggressiveness of familial prostate cancer.
Kupelian PA; Reddy CA; Reuther AM; Mahadevan A; Ciezki JP; Klein EA
J Clin Oncol; 2006 Jul; 24(21):3445-50. PubMed ID: 16849760
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population.
Nakazato H; Suzuki K; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Ito K; Kurokawa K; Yamanaka H
Anticancer Res; 2003; 23(3C):2897-902. PubMed ID: 12926131
[TBL] [Abstract][Full Text] [Related]
20. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
